Cancer Research at the Fralin Biomedical Research Institute
At the Fralin Biomedical Research Institute, dedicated investigators in two centers strive to improve therapies and better outcomes in a range of cancers, from childhood cancers to breast cancer to brain cancers, including acute myeloid leukemia, diffuse midline glioma, and glioblastoma multiforme. Research teams are exploring drug development, the role of genes in cancer, focused ultrasound and biomatarials to improve existing cancer treatments such as immunotherapy. With laboratories in Roanoke, Virginia, and Washington, D.C., the research institute devotes significant resources to making groundbreaking discoveries to address the challenges of the second leading cause of death globally.
-
Home Item
Jenny Munson, Ph.D. , homeProfessor, Director, Cancer Research Center – Roanoke
-
Home Item
Christopher Hourigan, DM, DPhil, FRCP , homeProfessor, Director, Cancer Research Center – D.C.
-
Article Item
-
Article Item
-
Article Item
‘Every time we wait, we lose someone who might have made it’ , article Date: Jun 27, 2025 -
-
Article ItemLymph node on a chip: New immune system model developed to enhance precision medicine research , article
The Fralin Biomedical Research Institute at VTC’s Munson lab completed one element of an engineered tissue model that could advance medical and drug testing and provide a new tool for precision medicine.
Date: Jun 18, 2025 - -
Article ItemNew study aims to improve treatment for pediatric brain cancer , article
With grant support from The Children’s Cancer Foundation Inc., a nonprofit that serves the Baltimore-Washington region, Fralin Biomedical Research Institute scientists are focused on ending an glioblastoma.
Date: Jun 09, 2025 - -
Article ItemVirginia Tech student named Goldwater Scholar , article
Rising senior Lacey Ngo has been awarded a 2025 Goldwater Scholarship, a federal merit award for undergraduate science, mathematics, and engineering students.
Date: Jun 02, 2025 - -
Article ItemVirginia Tech researchers find promise in a new peptide drug to combat a deadly brain cancer , article
Fralin Biomedical Research Institute scientists were able to slow glioblastoma progression in lab and animal studies by targeting treatment-resistant cancer cells.
Date: May 30, 2025 - -
Article ItemAI-backed saliva test shows promise for flagging chemotherapy risk, early results indicate , article
Fralin Biomedical Research Institute at VTC scientists developed a saliva-based artificial intelligence screening method that could flag patients at risk for dangerous side effects from a widely used chemotherapy drug.
Date: Apr 22, 2025 - -
Article ItemResearchers investigate low-intensity electrical pulses to help the immune system fight cancer , article
High-intensity electrical pulses have been medically used to destroy tumors while sparing healthy tissue. But lower-intensity pulses may have a different effect — they reshape the battlefield, making tumors more vulnerable to the body’s own defenses.
Date: Apr 17, 2025 - -
Article ItemFinding community and focus in interdisciplinary cancer research , article
Doctoral student Blanka Bordas had not planned to work in Washington, D.C., as she earned her degree, but opted to do so for the chance to work with an outstanding mentor on cancer research
Date: Apr 11, 2025 -
Page 1 of 13 | 128 Results
Recent Media Coverage
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemJohns Hopkins: Student Spotlight: Gege Gui, ScM '18 , redirect
Gege Gui, ScM '18, is a fifth-year PhD candidate in the Department of Biostatistics, as well as a Research Scientist at Hourigan Lab where she has worked since 2018.
Date: Feb 25, 2025 -
Page 1 of 27 | 264 Results